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Summary Chromosomal deletions at Xp22.3 appear to influence vulnerability to the neuro-
developmental disorders attention deficit hyperactivity disorder (ADHD) and autism. 39,XY*O
mice, which lack the murine orthologue of the Xp22.3 ADHD candidate gene STS (encoding steroid
sulfatase), exhibit behavioural phenotypes relevant to such disorders (e.g. hyperactivity),
elevated hippocampal serotonin (5-HT) levels, and reduced serum levels of dehydroepiandroster-
one (DHEA). Here we initially show that 39,XY*O mice are also deficient for the recently-
characterised murine orthologue of the Xp22.3 autism candidate gene ASMT (encoding acet-
ylserotonin-O-methyltransferase). Subsequently, to specify potential behavioural correlates of
elevated hippocampal 5-HT arising due to the genetic lesion, we compared 39,XY*O MF1 mice to
40,XY MF1 mice on behavioural tasks taxing hippocampal and/or 5-HT function (a ‘foraging’ task,
an object-location task, and the 1-choice serial reaction time task of impulsivity). Although Sts/
Asmt deficiency did not influence foraging behaviour, reactivity to familiar objects in novel
locations, or ‘ability to wait’, it did result in markedly increased response rates; these rates
correlated with hippocampal 5-HT levels and are likely to index behavioural perseveration, a
frequent feature of neurodevelopmental disorders. Additionally, we show that whilst there was no
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systematic relationship between serum DHEA levels and hippocampal 5-HT levels across 39,XY*O and
40,XY mice, there was a significant inverse linear correlation between serum DHEA levels and
activity. Our data suggest that deficiency for genes within Xp22.3 could influence core behavioural
features of neurodevelopmental disorders via dissociable effects on hippocampal neurochemistry
and steroid hormone levels, and that the mediating neurobiological mechanisms may be investigated
in the 39,XY*O model.
# 2012 Elsevier Ltd. 
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Potentially pathogenic cytogenetic deletions within Xp22.3
are relatively common in patients with autistic spectrum
disorders (ASDs) (Thomas et al., 1999; Chocholska et al.,
2006; Vorstman et al., 2006; Kent et al., 2008; Shinawi et al.,
2009), characterised by social/communication impairments,
restricted interests or repetitive/stereotyped behaviours,
hyperactivity and anxiety (O’Hare, 2009). Xp22.3 deletions
have also been reported in cases of attention deficit hyper-
activity disorder (ADHD) (Boycott et al., 2003; Lonardo et al.,
2007; Kent et al., 2008), a second neurodevelopmental con-
dition characterised by inattention, pathological impulsivity
and hyperactivity (Thapar et al., 2012) which is commonly
comorbid with autism and which is thought to share over-
lapping genetic aetiology (Rommelse et al., 2010); indivi-
duals with ADHD may also display a heightened tendency
towards behavioural perseveration (Fischer et al., 2005;
Tsuchiya et al., 2005).
Several Xp22.3 genes represent good candidates for con-
ferring vulnerability to psychiatric illness: functional muta-
tions within NLGN4X (encoding the synaptic neuroligin 4X
protein) have been reported in cases of autism (Jamain et al.,
2003; Laumonnier et al., 2004), whilst mutations within
ASMT (encoding the acetylserotonin-O-methyltransferase
enzyme involved in the biosynthesis of melatonin from ser-
otonin) have been seen in individuals with autism (Melke
et al., 2008; Jonsson et al., 2010) and ADHD (Chaste et al.,
2011). Cytogenetic deletions encompassing STS (encoding
the enzyme steroid sulfatase (Sts)) and inactivating muta-
tions/genetic variants within the gene can influence ADHD
risk and presentation (Kent et al., 2008; Stergiakouli et al.,
2011). Sts cleaves sulfate groups from various steroid hor-
mones, thereby altering their potency and specificity at a
variety of neurotransmitter receptors (Reed et al., 2005).
Besides putative effects on neurodevelopmental disorders,
Sts deficiency has recently been implicated in postpartum
psychosis risk (Davies, 2012). Understanding how lack of the
gene products above impacts upon neurobiology and beha-
viour will be important for illuminating the pathophysiolo-
gical basis of multiple psychiatric conditions.
39,XY*O mice, which possess a single sex chromosome
composed of an X and Y chromosome fused at the pseu-
doautosomal region (PAR) (Odorisio et al., 1998), exhibit
behavioural and endocrinological phenotypes of relevance
to ADHD and ASDs including inattention (Davies et al.,
2009), hyperactivity, heightened emotional reactivity,
occasional aggression, and reduced systemic levels of a
major Sts product, dehydroepiandrosterone (DHEA)
(Trent et al., 2012b). Analysis of whole-tissue neurochem-
ical levels across the brain in 39,XY*O and 40,XY mice
indicated reduced levels of the noradrenaline metabolite3-methoxy-4-hydroxyphenylglycol  (MOPEG) in the striatum
and elevated levels of striatal and hippocampal serotonin
(5-hydroxytrypamine, 5-HT) in the former group. The hip-
pocampal 5-HT finding was highly significant, and there
appeared to be a particularly strong correlation between
hippocampal 5-HT levels and aspects of behavioural func-
tion (Trent et al., 2012a). Until recently, Sts was the only
known gene within the mouse PAR and thus represented
the sole candidate for the above phenotypes. However,
emerging genetic data (Kasahara et al., 2010 and
www.ncbi.nlm.nih.gov/projects/mapview) have suggested
that the Asmt and Erdr1 (erythroid differentiation regu-
lator 1) genes, together with the poorly annotated
LOC100861696, and G530011O06Rik genes, may also be
pseudoautosomal; the chromosomal locations of the for-
mer two have recently been changed from ‘unknown’ to
sex-linked in the Mouse Genome Informatics database
(www.informatics.jax.org, updated October 2012). Hence,
we initially examined the extent of the deleted region in
the 39,XY*O model to ascertain whether the absence of
genes other than Sts could contribute to its phenotype.
Given our previous data suggesting altered hippocampal
neurochemistry in Sts-deficient 39,XY*O mice (Trent et al.,
2012a), and the observation that acute Sts inhibition can
result in altered hippocampal neurochemistry (Rhodes et al.,
1997), we next tested 39,XY*O mice on two behavioural tasks
sensitive to hippocampal function to specify potential beha-
vioural correlates of these neurochemical changes: (i) an
ethobiologically-relevant spatial navigation (‘foraging’) task
conceptually analogous to ‘open field’ tasks used in rodents
and pigeons (Hermes et al., 2005; Pearce et al., 2005), in
which subjects are required to visit and consume reinforcer
from baited pots in the most parsimonious manner possible
and (ii) an ‘object-location task’, in which the relative
exploration times of objects in a sample spatial context,
and of the same ‘familiar’ objects in a revised spatial con-
text, are compared (Good et al., 2007). Being land-based and
appetitively-motivated (in the case of the foraging task),
neither task should be significantly confounded by factors
such as anxiety and swimming ability inherent in other
commonly-used tasks of hippocampal function such as the
Morris Water Maze; this was particularly important given
evidence for heightened emotionality in 39,XY*O mice (Trent
et al., 2012b).
There is prior evidence that reducing hippocampal 5-HT
levels via lesion of the median raphe nucleus in rats increases
premature responding (i.e. decreases ‘ability to wait’) in the
5-choice serial reaction time task (5-CSRTT) (Harrison et al.,
1997). We have previously shown that 39,XY*O mice show a
significant reduction in premature responding in the 5-CSRTT
(Davies et al., 2009). Here, we compared the performance of
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5-CSRTT in which the stimulus was only presented at a central
location (1-choice SRTT) to assay ‘ability to wait’ in the
absence of any confounding effects on visuospatial attention;
we then measured hippocampal 5-HT levels in these mice. We
hypothesised that 39,XY*O mice would exhibit reduced pre-
mature responding relative to wildtype mice, and that hip-
pocampal 5-HT levels would be inversely correlated with
levels of premature responding.
We previously proposed that reduced DHEA levels in
39,XY*O mice might result in elevated hippocampal 5-HT
levels by increasing neural tryptophan hydroxylase activity
(Trent et al., 2012a). Here, we indirectly tested this idea by
assaying DHEA levels and hippocampal 5-HT levels within the
same animals, predicting an inverse relationship between the
two variables. Finally, in humans, there is preliminary data
suggesting that blood levels of DHEA in subjects diagnosed
with ADHD are inversely correlated with symptom severity,
notably measures of hyperactivity (Strous et al., 2001; Wang
et al., 2011). Our experimental set-up allowed us to expli-
citly test for a relationship between serum DHEA levels and
locomotor activity in the absence of confounds associated
with testing in clinical populations such as previous or current
pharmacotherapy.
2. Methods
2.1. Subjects and animal husbandry
39,XY*O and 40,XY mice were bred and genotyped at the MRC
National Institute for Medical Research, London, UK as
described previously (Davies et al., 2009; Trent et al.,
2012a,b), before being transferred to Cardiff University for
behavioural testing. In Cardiff, subjects were treated with
Baytril and Norodine-24 antibiotics for one month in a nega-
tive-pressure isolator to cure a Pasteurella pneumotropica
infection prior to release onto the open racks. The mice were
then housed in a holding room (1—4 mice of the same
karyotype per cage) maintained at 21  2 8C and 50  10%
humidity, with a 12-h light—dark cycle (lights on at 0700 h).
Single-housing of some 39,XY*O mice was necessary to pre-
vent fighting, and did not appear to impact significantly on
the pertinent measures assayed here (data not shown).
Behavioural testing was motivated where necessary by using
a 10% condensed milk reinforcer (Nestle Ltd.), previously
shown to be highly palatable (>70% preference over tap
water) and equivalently preferred by 39,XY*O and 40,XY mice
(Davies et al., 2009; Trent et al., 2012a); prior to behavioural
testing, mice were subject to a water restriction schedule,
whereby they received 4 h of water per day for four days, and
2 h/day thereafter. All experiments were conducted accord-
ing to the Animal (Scientific Procedures) Act 1986. All efforts
were made to minimise animal suffering, to reduce the
number of animals used, and to utilise alternatives to in vivo
techniques, if available.
2.2. Genetic analysis
Genomic DNA was obtained from 40,XY (n = 2) and 39,XY*O
(n = 2) brain tissue as described in Davies et al. (2009). Asmt,
Erdr1, Mid1 and Sts genes were amplified by PCR in separatemixes: 18.25 ml sterile water, 2.5 ml 10 buffer, 1.0 ml 5 mM
dNTPs, 200 nM forward and reverse primers, 0.25 ml HotStar
Taq polymerase, 1.0 ml DNA solution under the following
conditions: 94 8C for 15 min [94 8C for 40 s, 60 8C for 40 s,
72 8C for 1 min 30 s, for 40 cycles], 72 8C for 10 min. Primers
used were as follows: AsmtF: 50-AGGAGACCTGGAGCCTGTG-
30, AsmtR: 50-GTCTCGAACACGGTGACCTC-30, Erdr1F: 50-
TAGCCGCAGCTATGGTTTCT-30, Erdr1R: 50-CAGGCTTCC-
TACCTTGTGGA-30, Mid1F: 50-AGCCTGTGGAGTCCATCAAC-30,
Mid1R: 50-GCTTTCAGGCACTCATCACA-30, StsF: 50-
GCTCGCTGACATCATCCTC-30, StsR: 50-CACCGATGCC-
CAGGTCGTC-30. Products were visualised on a 1.5% ethidium
bromide-stained agarose gel.
2.3. Foraging task
39,XY*O (n = 12) and 40,XY (n = 12) mice (8—10 months) were
run in a pseudorandom order between 1000 and 1500 h. After
shaping and habituation procedures, mice were given a series
of test and probe sessions (see Supplementary Material).
During five consecutive test sessions, mice were required
to collect drops of 10% condensed milk reinforcer from eight
pots; these sessions lasted until all reinforcers had been
collected, or for a maximum of 15 min. Main measures of
interest at baseline performance (i.e. test day 5) included
the number of reinforcers obtained within the time limit, the
latency to obtain these reinforcers, and the number of errors
made in obtaining the reinforcers (i.e. repeat visits to pre-
viously visited containers). The two subsequent probe ses-
sions were designed to test for any differential group effects
on the use of extra-maze cues, and on perseverative beha-
viour (as indexed by repeat visits to a single previously-
visited pot).
2.4. Object-location task
A randomly-selected subset of 39,XY*O (n = 8) and 40,XY
(n = 8) mice who had completed the foraging task were
run on this task between 1000 and 1500 h; these mice were
allowed ad libitum access to homecage food and water.
Following habituation to the test arena and the test objects,
subjects were given two test sessions, each composed of a
sample and test phase two minutes apart. In the sample
phase, mice were allowed to explore four objects located in a
square in the centre of the arena for a maximum of 10 min
(with exploration times equalised across karyotypes); in the
test phase, the two diagonally-opposed objects were
switched, and mice were allowed to explore the novel con-
figuration for 10 min. For test days one and two, the opposite
combination of objects was switched. Data were averaged
across test days one and two, with the main measure of
interest being the change in exploration of the ‘switched
objects’ in their novel configuration (test phase) relative to
their exploration in their initial configuration (sample phase).
Further experimental details are available in the Supplemen-
tary Material.
2.5. 1-Choice serial reaction time task (1-CSRTT)
Testing was performed in 9-hole boxes (Campden Instru-
ments, UK)(Humby et al., 1999) between 1000 and 1500 h.
Molecular mechanisms associated with behavioural phenotypes in 39,XY*O mice 137339,XY*O (n = 12) and 40,XY (n = 11) mice aged 8—10 months
were trained to make a rapid nosepoke response to a light
stimulus presented in the central hole in order to obtain
20 ml of 10% condensed milk reinforcer (Nestle Ltd.). Initial
shaping was as described previously for the 5-CSRTT
(Humby et al., 1999) with one session per day, with the
stimulus duration being reduced in a stepwise manner from
32 s to 1 s at baseline once criteria had been met for two
consecutive sessions (>50 trials, >80% accuracy, <30%
omissions). At baseline, the latency between trial initia-
tion by panel push and stimulus onset (i.e. the inter-trial
interval, ITI) was fixed at 5 s. Once stable baseline per-
formance had been achieved (using the aforementioned
criteria), subjects were given three manipulation sessions,
with at least one stable baseline session between each. In
the first manipulation session (LITI), the ITI was pseudor-
andomly varied between 5, 6, 7 and 8 s. In the second
manipulation session (ELITI), the ITI was pseudorandomly
varied between 5, 7, 9 and 11 s. In the final manipulation
session (I10), the ITI was held constant at 10 s. The main
measures of interest were: number of trials, accuracy, %
omissions, number of premature nosepokes within ITI
(main index of ‘ability to wait’), total number of nose-
pokes, number of panel pushes to initiate trials, and
activity (indexed by infra-red beam breaks).
2.6. Locomotor activity
Locomotor activity was assayed in mice on ad libitum food
and water who managed to acquire and complete the 1-
CSRTT (39,XY*O: n = 12, and 40,XY: n = 6). Testing was con-
ducted in clear perspex cages (21 cm  36 cm  20 cm,
l  b  h) fitted with an infrared beam 3 cm from either
end and 1 cm from the floor. Mice were allowed to explore
freely for 3 h; for the first hour the test was run under dim
lighting (20 lx) and for the remaining time it was run in the
dark; the onset of the dark period coincided with the onset of
the dark period in the holding room. The main measure of
activity was the number of beam breaks throughout the test
period.
2.7. Brain dissection and high performance
liquid chromatography (HPLC) for determination
of 5-HT levels
Mice (aged 10—12 months) that had undergone testing on the
1-CSRTT and locomotor activity paradigms were allowed ad
libitum access to water and food prior to being culled by
cervical dislocation. Brains were removed immediately and
the entire hippocampus was dissected from the right hemi-
sphere and weighed using a microbalance before being frozen
on dry ice and stored at 80 8C. Samples were processed and
analysed for wet weight-normalised monoamine levels as
described previously (Trent et al., 2012a).
2.8. DHEA analysis
Trunk blood was collected between 1000 and 1500 h from
39,XY*O (n = 18) and 40,XY (n = 13) mice on ad libitum food
and water, including the subset used for hippocampal dis-
sections. Serum was extracted, and analysed for DHEA levelsby enzyme-linked immunosorbent assay (ELISA) as described
in Trent et al., 2012b. Sample outliers (i.e. values >2 stan-
dard deviations below or above the group mean) were
excluded from the analysis.
2.9. Statistics
Data were analysed using SPSS 18.0 (IBM Corporation, New
York). Data were tested for normality using the Shapiro—
Wilks test. Normal data were analysed by unpaired two-
tailed t-test/one-way ANOVA/two-way repeated measures
ANOVA, with factors of KARYOTYPE and TIMEPOINT. Skewed
data were transformed before parametric analysis as appro-
priate. Where sphericity assumptions were violated in two-
way ANOVA, Greenhouse—Geisser corrected degrees of free-
dom values are presented. Non-parametric data were ana-
lysed by two-tailed Mann—Whitney U test. For the
correlational analyses, Pearson’s test was used for normally
distributed data, and Spearman’s test for non-normally dis-
tributed data. Frequency data were analysed by chi-squared
test, or Fisher Exact Test if cells contained fewer than five
values. p-Values of <0.05 were regarded as significant. Data
are presented as mean values  standard error of the mean.
3. Results
3.1. Specification of the genetic lesion in
39,XY*O mice
PCR analysis indicated that the genes Sts and Asmt are both
deleted in the 39,XY*O mouse, but that neither Mid1 (span-
ning the pseudoautosomal boundary) nor Erdr1 is (Fig. 1A);
LOC100861696 and G530011O06Rik which are located
between Mid1 and Erdr1 (Fig. 1B) will also be retained in
39,XY*O mice. These data help to refine the genetic lesion in
39,XY*O mice, indicating that the X—Y fusion occurs some-
where between the Erdr1 and Sts genes (Fig. 1C).
3.2. Hippocampal 5-HT levels
5-HT levels in one 39,XY*O sample could not be reliably
determined. Consistent with our previous data (Trent
et al., 2012a), in this separate experimental cohort, we
observed a highly significant increase in hippocampal 5-HT
levels in 39,XY*O tissue relative to 40,XY (529  29 pg/mg vs.
340  40 pg/mg respectively, t[15] = 3.835, p = 0.002). 5-
HT turnover (as indexed by the ratio of 5-hydroxyindolacetic
acid:5-HT levels) was again also found to be significantly
reduced (by 26%) in the hippocampus of 39,XY*O mice
relative to 40,XY mice (data not shown).
3.3. ‘Foraging’ task
At baseline (i.e. test day 5), there was no between-group
difference in the number of mice collecting reinforcer from
all eight containers within the 15 min time limit (7 40,XY
mice, 10 39,XY*O mice, two-tailed Fisher Exact Test,
p = 0.37); 39,XY*O mice which completed the task within
the time limit did so significantly more rapidly than those
40,XY mice which did (326  42 s vs. 593  92 s,
t[15] = 2.914, p = 0.011); this faster completion latency is
Figure 1 Presence of putative pseudoautosomal genes in 40,XY (n = 2) and 39,XY*O (n = 2) mice as indexed by PCR from genomic DNA
(A); Asmt and Sts genes are deleted in the latter group, whilst the Erdr1 and Mid1 genes (and therefore G530011O06Rik and
LOC100861696 genes) are retained. These data indicate that the pseudoautosomal regions of the X and Y chromosomes (B) form an end-
to-end fusion at the region between Erdr1 and Sts in 39,XY*O mice (C).
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enhanced cognition as 39,XY*O mice made significantly more
quadrant crosses during the initial arena habituation than
40,XY mice (84  7 vs. 59  4, t[15] = 2.691, p = 0.017).
39,XY*O and 40,XY mice which completed the task did not
differ in their total errors (11  2 vs. 13  2 respectively,
t[15] = 0.546, p = 0.593); as expected, the majority of these
errors were made during the second half of the task (i.e.
following consumption from the fourth container) when the
likelihood of correctly identifying a reinforced container by
chance was reduced (39,XY*O: 10  2 and 40,XY: 11  3). The
fact that both groups of mice made such errors suggests that
neither were using odour cues to any great extent, or that
neither were using such cues effectively; furthermore, we
did not detect any evidence that mice were using kinaes-
thetic mediating strategies such as consistently visiting pots
in a clockwise direction to complete the task. Hence, the task
might reasonably be regarded as taxing ‘spatial working
memory’. Equally low levels of defecation were seen in both
groups of mice (39,XY*O: 0.4  0.3 faecal boli, 40,XY:
0.7  0.3 faecal boli, p = 0.410) consistent with generally
low levels of emotional reactivity within the task across both
groups.
In the absence of extra-maze cues, there was no between-
group difference in the number of mice collecting reinforcer
from all eight containers within the 15 min time limit (9 40,XY
mice, 11 39,XY*O mice, two-tailed Fisher Exact Test,
p = 0.59). Mutant and wildtype mice completed this variant
of the task with equivalent latencies (386  62 s and
447  53 s respectively, t[18] = 0.727, p = 0.476). As pre-
dicted, mice completing the task tended to make more errors
in the absence of extra-maze cues than in their presence, but
again, there was no significant effect of KARYOTYPE (39,XY*O:
12  3, 40,XY: 14  4, p = 0.603). These data suggest that
whilst both groups of mice were using extra-maze cues to
guide their behaviour to some extent, they were equivalently
more reliant upon intra-maze and/or kinaesthetic cues to
complete the task.
11 39,XY*O and 11 40,XY mice consumed the reinforcer
within the 10 min maximum test period in the one-pot taskvariant ( p = 1.0). 39,XY*O mice were significantly faster to
consume the one sample than 40,XY mice (70  20 s vs.
127  18 s respectively, t[20] = 2.126, p = 0.046), and made
more than twice the number of repeat visits to the pot once
the reinforcer had been consumed (15  2 vs. 7  1 respec-
tively, t[20] = 3.647, p = 0.002); the number of repeat visits
in the 39,XY*O group remained significantly increased even
after normalising for the fact that these mice had a signifi-
cantly longer time interval in which to make such visits (100
repeat visits/s: 2.8  0.4 s1 vs. 1.4  0.2 s1 respectively,
t[20] = 3.586, p = 0.002). There was a highly significant
positive correlation between the number of times an animal
re-visited a pot in which the reinforcer had already been
consumed and its activity in the ‘open field’ session
(r = 0.633, p = 0.002).
3.4. Object-location task
During the 10 min sample phase, total investigation time (all
four objects) was 62  5 s across both groups, and as in the
foraging task, emotional reactivity as indexed by faecal boli
number was equally low across both groups (39,XY*O:
2.8  1.1, 40,XY: 1.8  0.7, p = 0.798). 39,XY*O and 40,XY
groups spent approximately half of their time exploring the
two objects to be swapped in the test phase (50  2% vs.
50  2% respectively, t[14] = 0.246, p = 0.809). During the
10 min test phase, both 39,XY*O and 40,XY groups spent more
time investigating all four objects than in the sample phase,
but again there was no effect of KARYOTYPE on this measure
(39,XY*O: 71  9 s, 40,XY: 91  7 s, p = 0.074). At test, both
groups showed equivalent, and >50%, exploration of the two
objects that had been swapped (39,XY*O: 59  3%, 40,XY:
62  4%, p = 0.208). As expected, both 39,XY*O and 40,XY
groups showed a significant increase in exploration of the
familiar objects in their novel location relative to their
exploration in the original location (one-tailed one-sample
t-tests: t[7] = 3.437, p = 0.005 and t[7] = 2.220, p = 0.031
respectively), but there was no significant effect of KARYO-
TYPE on this measure (increase in exploration, 40,XY:
Table 1 Data from the three 1-CSRTT manipulation sessions for 40,XY (n = 6) and 39,XY*O mice (n = 12).
Manipulation Karyotype Trial number % Accuracy % Omissions Nosepokes Panel pushes Beam breaksy
LITI 40,XY 51  2 94  3 41  14 42  9 157  28 721  292
39,XY*O 70  5 ** 96  1 9  2 98  4** 172  22 863  140
ELITI 40,XY 50  4 97  1 23  2 54  5 146  26 537  51
39,XY*O 59  5 96  1 14  3* 99  6** 173  18 905  146 *
I10 40,XY 38  7 93  5 24  7 45  9 118  30 465  106
39,XY*O 46  5 97  1 13  4 87  8** 149  17 912  124 *
* p < 0.05.
** p < 0.01.
y Activity data was not collected for one 40,XY mouse and two 39,XY*O mice due to technical problems with the infra-red beams.
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p = 0.563).
3.5. 1-Choice serial reaction time task
All 12 39,XY*O mice tested met stable baseline performance
criteria after training, but only 6 of the initial cohort of 40,XY
mice met these criteria; the 5 40,XY mice who did not failed
to perform sufficient numbers of trials due to low levels of
panel pushing and/or nosepoking behaviour. Overall trial
number, accuracy, omissions, nosepoke, panel push and
activity data for the three manipulation sessions are
described in Table 1. The most striking finding was that
mutant mice tended to make significantly more responses
(nosepokes) than their wildtype counterparts across all three
sessions, but equivalent numbers of trial initiations (panel
pushes). We also noted greater overall activity in the mutant
mice during testing as indexed by the number of infra-red
beam breaks. The number of nosepokes performed was not
directly related to the general activity of the mice as indexed
by infra-red beam breaks for any of the three manipulation
sessions (LITI: Spearman correlation coefficient = 0.146,
p = 0.603, ELITI: r = 0.260, p = 0.350, I10: r = 0.382,
p = 0.161).
As our main index of impulsivity in this task (premature
nosepokes) could potentially be confounded by the group
difference in response behaviour, we normalised for general
nosepoking rates in our analysis. Whilst the pattern of data
from the LITI and ELITI manipulations was as expected (i.e.
more ‘normalised’ premature responses for longer ITIs,
effect of ITI: F[3,48] = 9.538, p < 0.001 andInter-trial interval (s)
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Figure 2 Number of premature nosepokes normalised for total nose
sessions in which the inter-trial interval (ITI) was pseudorandomly var
the ITI was held constant at 10 s (C).F[3,48] = 18.935, p < 0.001 respectively), there was no
effect of KARYOTYPE on either manipulation
(F[1,16] = 0.329, p = 0.574 and F[1,16] = 1.051, p = 0.321
respectively) nor any KARYOTYPE  ITI interaction
(F[3,48] = 1.530, p = 0.219 and F[3,48] = 0.318, p = 0.812
respectively) (Fig. 2A and B). In the I10 manipulation, both
groups of mice tended to make high numbers of normalised
premature responses as predicted for this consistently
extended ITI, but again there was no significant effect of
KARYOTYPE (t[16] = 0.432, p = 0.671, Fig. 2C).
Hippocampal lesions have previously been shown to influ-
ence response rates in rodents in an appetitively-motivated
operant task (Shull and Holloway, 1985). Hence, we tested
whether the increased nosepoking behaviour seen in 39,XY*O
mice could be explained by their elevated hippocampal 5-HT
levels. We observed significant positive correlations
between hippocampal 5-HT levels and total nosepokes in
the LITI and ELITI manipulation sessions (Spearman correla-
tion coefficient = 0.571, p = 0.017 and r = 0.579, p = 0.015,
respectively); data from the ELITI session are shown in
Fig. 3A. Whilst there was a trend towards correlation
between hippocampal 5-HT and total nosepokes in the I10
session this was non-significant (r = 0.463, p = 0.061). Hip-
pocampal 5-HT levels correlated specifically with nosepok-
ing behaviour, in that there was no relationship with total
panel pushes/beam breaks across any of the three manip-
ulation sessions (panel pushes: LITI: r = 0.217, p = 0.404,
ELITI: r = 0.351, p = 0.167, I10: r = 0.243, p = 0.346, beam
breaks: LITI: r = 0.056, p = 0.850, ELITI: Spearman correla-
tion coefficient = 0.024, p = 0.935, I10: r = 0.132,
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Figure 3 Relationship between nosepoking behaviour and hippocampal 5-HT in 39,XY*O (n = 12, white circles) and 40,XY (n = 6, black
circles) mice (A), and the allocation of these nosepokes across different phases of the task (B) during the ELITI manipulation session.
1376 S. Trent et al.In order to specify more precisely how nosepoking beha-
viour differed between 39,XY*O and 40,XY mice, post hoc, we
subdivided the central nosepokes made during the ELITI
manipulation into five categories according to when they
were made: (i) after completion of a trial but pending
initiation of a subsequent trial (‘waiting period’), (ii) within
the ITI (‘premature responses’), (iii) during stimulus presen-
tation, (iv) within the 5 s ‘eating’ period following a correct
response (traditionally regarded as ‘perseverative responses’
(Robbins, 2002)) or (v) within a time-out period. Unsurpris-
ingly, given the high degree of stimulus control required to
complete the task, the majority of nosepokes were made
during stimulus presentation (Fig. 3B). Although 39,XY*O mice
tended to make more nosepokes than 40,XY mice across all
five response categories, only for ‘perseverative’ nosepokes
was there a significant effect of KARYOTYPE
(t[11.8] = 3.016, p = 0.011, Fig. 3B); effect of KARYOTYPE
for ‘waiting period’: p = 0.820, for premature responses:
t[16] = 1.906, p = 0.075, during stimulus presentation:
t[16] = 1.476, p = 0.159, for timeout: p = 0.067.
3.6. DHEA levels and correlations with
hippocampal 5-HT and locomotor activity
Two mice (one 39,XY*O, one 40,XY) were excluded from the
DHEA analysis as outliers. We observed a highly significant
decrease in serum DHEA levels in 39,XY*O mice relative toSerum DHEA concentration (ng/ml)
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Figure 4 Relationship between locomotor activity (as indexed by in
levels in 39,XY*O (n = 12, white circles) and 40,XY (n = 6, black circles)
subsequent 2 h of testing in the dark (B).40,XY mice (0.25  0.04 ng/ml vs. 0.46  0.06 ng/ml,
t[27] = 3.094, p = 0.005). Investigating the relationship
between hippocampal 5-HT levels and serum DHEA levels
in mice in which both measures were assessed suggested no
significant linear relationship (r = 0.129, p = 0.621, Supple-
mentary Fig. 4). We found that 39,XY*O mice were signifi-
cantly more active than 40,XY mice as indexed by the total
number of infra-red beam breaks during a 3-h test session
(4272  543 vs. 2118  289, p = 0.003, Supplementary Fig.
5), recapitulating our previous findings (Trent et al., 2012b).
There was a significant inverse correlation between total
beam breaks and serum DHEA levels (Spearman correlation
coefficient = 0.480, p = 0.044); this relationship was stron-
ger during the first hour of the test (Spearman correlation
coefficient = 0.618, p = 0.006, Fig. 4A) than during the
remaining 2 h (Spearman correlation coefficient = 0.386,
p = 0.113, Fig. 4B).
4. Discussion
Deficiency for genes within Xp22.3 may influence vulnerabil-
ity to, and the symptoms of, neurodevelopmental disorders
including ADHD and ASDs. We have shown here that the
39,XY*O mouse, which exhibits behavioural and endocrinolo-
gical features relevant to such disorders, lacks the murine
orthologues of the Xp22.3 genes STS and ASMT previously
implicated in psychiatric phenotypes; this finding confirmsSerum DHEA concentration (ng/ml)
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fra-red beam breaks) and serum dehydroepiandrosterone (DHEA)
 mice during the first hour of testing in the light (A) and during the
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clarifies the genetic lesion in 39,XY*O mice. The main purpose
of the experiments described herein was threefold: (i) to
identify potential behavioural correlates of increased hippo-
campal 5-HT levels in 39,XY*O mice using tasks known to be
sensitive to hippocampal and/or serotonergic function, (ii) to
test whether reduced serum DHEA levels in 39,XY*O mice
were systematically related to hippocampal 5-HT levels, and
(iii) to investigate whether serum DHEA levels were inversely
correlated with locomotor activity, as predicted by the ADHD
literature.
With regard to the first aim, we found no evidence that
elevated hippocampal 5-HT levels in 39,XY*O mice resulted in
altered ‘foraging’ behaviour or in reactivity to familiar
objects in novel locations; nor did we find any evidence
for an enhanced ‘ability to wait’, one aspect of impulsive
function, in 39,XY*O mice. The finding regarding ‘ability to
wait’ contrasts somewhat with our recent 5-CSRTT data
which hinted at reduced premature responding in 39,XY*O
mice relative to 40,XY subjects, equivalent total nosepoking
across groups, and reduced nosepokes per trial (Davies et al.,
2009; unpublished data). One possible explanation for this
discrepancy is that our previous work examined responding
across an array, and thus had a significant visuospatial atten-
tional component; here, this component was reduced by
assaying responding at just one location. We speculate,
tentatively, that a reduced tendency to respond prematurely
in situations where the location of the stimulus is unpredict-
able (i.e. in the 5-CSRTT), but a tendency to respond more
frequently in predictable situations (i.e. where the stimulus
location is invariant), may reflect altered decision-making in
39,XY*O mice, a cognitive construct known to be sensitive to
5-HT manipulations (de Visser et al., 2011).
39,XY*O mice exhibited an increased tendency to investi-
gate the location of a previously consumed reinforcer (‘fora-
ging’ task), and an increased tendency to respond in the 1-
CSRTT, relative to 40,XY mice. The first finding may simply be
a function of the greater activity of the 39,XY*O mice within
the arena; alternatively (or additionally), given that the mice
have to actively make a choice to investigate the pot, it may
reflect an elevated level of ‘checking’ behaviour, or perse-
veration of an unrewarded response, in these mice. The
second finding, which appeared to be related to hippocampal
5-HT levels but not general activity or motivation (as indexed
by panel pushing behaviour), could also be explained by
increased perseveration in the mutant mice, particularly
given that they made significantly more redundant nosepokes
following a correct response. 39,XY*O mice achieve higher
scores than 40,XY mice on a progressive ratio (PR) task in
which subjects must make increasingly high numbers of
nosepokes in a central aperture for reinforcement (Trent
et al., 2012a); as this nosepoking behaviour correlated with
hippocampal 5-HT levels but not with general activity levels,
we speculated previously that rather than reflecting
enhanced motivation, the altered performance of the
39,XY*O mice on the PR task may reflect an elevated tendency
to nosepoke perseveratively (Trent et al., 2012a). Our cur-
rent data support this idea, and strengthen the notion that
deficiency for Sts and/or Asmt may predispose to persevera-
tive behavioural patterns via influencing levels of hippocam-
pal 5-HT. As Sts is expressed in the hippocampus and is known
to influence hippocampal neurochemistry (Rhodes et al.,1997) its deficiency represents the most convincing under-
lying candidate mechanism. Asmt brain expression appears
to be limited to the pineal gland (Kasahara et al., 2010);
hence, any behavioural and neurochemical sequelae arising
from its absence are likely to be indirect and mediated by
effects on systemic melatonin levels.
The idea that elevated hippocampal 5-HT results in
increased perseveration is consistent with the ‘persevera-
tion-inducing’ effects of hippocampal lesions in rodents
across a number of assays (e.g. Dalland, 1970; Maruki
et al., 2001) including the 5-CSRTT (Le Pen et al., 2003),
and the effects of systemically-administered drugs targeting
the 5-HT system on perseveration in behavioural tasks (Brig-
man et al., 2010; Rhoads et al., 2012). Perseveration in serial
reaction time tasks has been suggested to be a form of
compulsive behaviour (Robbins, 2002). 40,XY and 39,XY*O
mice do not differ on a marble-burying task thought to index
aspects of compulsivity (Trent et al., 2012a), and so it is likely
that the neural substrates underlying marble-burying beha-
viour and perseverative responding in 39,XY*O mice are
largely dissociable. In order to establish a causal relationship
between hippocampal 5-HT levels and perseverative beha-
viour in 39,XY*O mice rather than the association suggested
here, it would be worthwhile examining the behavioural
effects of drugs targetting the 5-HT system infused directly
into the hippocampus. It may also be useful to examine the
extent to which heightened perseveration in 39,XY*O mice is
manifest across other paradigms taxing behavioural flexibil-
ity such as reversal learning. Prenatal administration of the
teratogen valproic acid in rats, a model of autism, results in
both altered hippocampal 5-HT levels and behavioural inflex-
ibility in adulthood (Narita et al., 2002; Dufour-Rainfray
et al., 2010; Bambini-Junior et al., 2011). Therefore, we
speculate that, in rodents (and possibly in humans), abnorm-
alities in hippocampal 5-HT levels giving rise to perseverative
behaviour may represent a common endpoint of multiple
genetic mutations or environmental insults, and may be
modifiable pharmacologically. How altered hippocampal 5-
HT levels might influence response rate/perseveration
remains to be clarified, but it is possible that the integ-
rity/function of neural projections from the hippocampus to
the medial prefrontal cortex, a brain region regulating com-
pulsive perseveration in rodents (Muir et al., 1996) may be
compromised.
We previously speculated that reduced DHEA levels in
39,XY*O mice might result in increased activity of tryptophan
hydroxylase, the rate-limiting enzyme in the 5-HT biosyn-
thetic pathway, and that this may ultimately explain ele-
vated 5-HT levels in the hippocampus of these mice (Trent
et al., 2012a). The lack of a relationship between systemic
DHEA levels and hippocampal 5-HT levels here argues against
this view, although it should be acknowledged that there may
be a stronger relationship at other developmental time-
points.
Work in individuals diagnosed with ADHD has suggested
that reduced levels of systemic DHEA may be particularly
associated with hyperactive symptomatology (Strous et al.,
2001). However, these studies have been difficult to interpret
given possible confounding demographic and treatment vari-
ables. Here, we have shown under controlled experimental
conditions that, consistent with the clinical literature, there
is evidence for an inverse relationship between systemic
1378 S. Trent et al.DHEA levels and activity. The correlation between DHEA
level and activity was particularly strong during the first
hour of the present assay, suggesting that levels of this
steroid may particularly impact upon activity within a novel
environment. Again, it will be important to establish a causal
relationship between DHEA levels and activity through phar-
macological manipulation of the former and recording of the
latter. Striatal 5-HT levels are elevated in 39,XY*O mice and
positively correlate with baseline activity (Trent et al.,
2012a). It is feasible that DHEA levels influence this axis,
and, in future work it would be interesting to test for a
relationship between systemic DHEA and striatal 5-HT
levels. Furthermore, striatal dopaminergic function has
been implicated in locomotor hyperactivity (Mehler-Wex
et al., 2006); as 39,XY*O mice show a trend towards elevated
dopamine levels in this brain region (Trent et al., 2012a), a
link between the genetic lesion in these mice, aberrant
striatal dopaminergic function, and hyperactivity might also
be considered.
Theoretically, the abnormal behavioural phenotypes we
have previously described in 39,XY*O mice (Davies et al.,
2009; Trent et al., 2012a,b) could be due to deficiency for
Sts and/or Asmt. However, as pharmacological manipula-
tion of the Sts axis influences attention and aggression
(Nicolas et al., 2001; Davies et al., 2009), and given strong
genetic and biochemical evidence for Sts in aggression
(Mortaud et al., 2010), these two phenotypes in 39,XY*O
mice are likely to result specifically from the absence of
Sts. The present data showing that locomotor activity
correlates with levels of the Sts product DHEA suggests
that hyperactivity in 39,XY*O mice is predominantly due to
loss of Sts (and its downstream endocrinological effects). It
is formally possible that the activity phenotype is subtly
affected by abnormalities in melatonin biosynthesis arising
from loss of the Asmt gene (Korf et al., 2003), although it
should be noted that 39,XY*O mice do not show any obvious
changes in photoperiod relative to 40,XY mice (Trent
et al., 2012b) as might be expected if the melatonin
system is severely compromised. In the future, should
the production of single gene Sts and Asmt knockout
rodents be possible, they could be used to unambiguously
dissociate between the behavioural and neural effects of
the two genes.
Our mouse data suggest that mutations or polymorphisms
resulting in reduced Sts and/or Asmt function may be asso-
ciated with rates of perseveration and altered hippocampal
serotonergic function in neurodevelopmental disorders of
behavioural inflexibility such as ADHD and autism; seroto-
nergic abnormalities have long been implicated in the patho-
genesis of autism (Scott and Deneris, 2005), and may also
influence ADHD symptomatology (Oades, 2007). The current
findings further suggest that genetic variants within STS
resulting in reduced systemic DHEA levels may also be asso-
ciated with hyperactivity. The 39,XY*O mouse has both face
and construct validity as a model for neurodevelopmental
disorders: it is inattentive, hyperactive, emotionally hyper-
reactive, aggressive and behaviourally inflexible, as a con-
sequence of lacking genes previously implicated in ADHD and
autism pathology. Further work in this mouse should enable
us to further elucidate the molecular, cellular, and biochem-
ical underpinnings of its abnormal behavioural and neural
phenotypes.Role of the funding sources
The funding bodies had no role in study design; in the
collection, analysis and interpretation of data; in the writing
of the report; and in the decision to submit the paper for
publication.
Conflict of interest
All authors declare that they have no conflicts of interest.
Acknowledgements
The study was funded by a Medical Research Council United
Kingdom (MRC, UK) New Investigator Research Grant to WD
(G0900636), by a Research Councils UK Fellowship to WD, by
grant PRIN2009 to TC, and by MRC funding (U117532009) to
OAO. We thank Mark Good, Martha Hvoslef-Eide and Laura
Middleton for helpful discussions regarding the behavioural
tasks.
Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.psyneuen.2012.12.002.
References
Bambini-Junior, V., Rodrigues, L., Behr, G.A., Moreira, J.C., Riesgo,
R., Gottfried, C., 2011. Animal model of autism induced by
prenatal exposure to valproate: behavioral changes and liver
parameters. Brain Res. 1408, 8—16.
Boycott, K.M., Parslow, M.I., Ross, J.L., Miller, I.P., Bech-Hansen,
N.T., MacLeod, P.M., 2003. A familial contiguous gene deletion
syndrome at Xp22.3 characterized by severe learning disabilities
and ADHD. Am. J. Med. Genet. A 122A, 139—147.
Brigman, J.L., Mathur, P., Harvey-White, J., Izquierdo, A., Saksida,
L.M., Bussey, T.J., Fox, S., Deneris, E., Murphy, D.L., Holmes, A.,
2010. Pharmacological or genetic inactivation of the serotonin
transporter improves reversal learning in mice. Cereb. Cortex 20,
1955—1963.
Chaste, P., Clement, N., Botros, H.G., Guillaume, J.L., Konyukh, M.,
Pagan, C., Scheid, I., Nygren, G., Anckarsater, H., Rastam, M.,
Stahlberg, O., Gillberg, I.C., Melke, J., Delorme, R., Leblond, C.,
Toro, R., Huguet, G., Fauchereau, F., Durand, C., Boudarene, L.,
Serrano, E., Lemiere, N., Launay, J.M., Leboyer, M., Jockers, R.,
Gillberg, C., Bourgeron, T., 2011. Genetic variations of the
melatonin pathway in patients with attention-deficit and hyper-
activity disorders. J. Pineal Res. 51, 394—399.
Chocholska, S., Rossier, E., Barbi, G., Kehrer-Sawatzki, H., 2006.
Molecular cytogenetic analysis of a familial interstitial deletion
Xp22.2-22.3 with a highly variable phenotype in female carriers.
Am. J. Med. Genet. A 140, 604—610.
Dalland, T., 1970. Response and stimulus perseveration in rats with
septal and dorsal hippocampal lesions. J. Comp. Physiol. Psychol.
71, 114—118.
Davies, W., 2012. Does steroid sulfatase deficiency influence post-
partum psychosis risk? Trends Mol. Med. 18, 256—262.
Davies, W., Humby, T., Kong, W., Otter, T., Burgoyne, P.S., Wilkinson,
L.S., 2009. Converging pharmacological and genetic evidence
indicates a role for steroid sulfatase in attention. Biol. Psychiatry
66, 360—367.
Molecular mechanisms associated with behavioural phenotypes in 39,XY*O mice 1379de Visser, L., Homberg, J.R., Mitsogiannis, M., Zeeb, F.D., Rivalan,
M., Fitoussi, A., Galhardo, V., van den Bos, R., Winstanley, C.A.,
Dellu-Hagedorn, F., 2011. Rodent versions of the Iowa gambling
task: opportunities and challenges for the understanding of deci-
sion-making. Front. Neurosci. 5, 109.
Dufour-Rainfray, D., Vourc’h, P., Le Guisquet, A.M., Garreau, L.,
Ternant, D., Bodard, S., Jaumain, E., Gulhan, Z., Belzung, C.,
Andres, C.R., Chalon, S., Guilloteau, D., 2010. Behavior and
serotonergic disorders in rats exposed prenatally to valproate:
a model for autism. Neurosci. Lett. 470, 55—59.
Fischer, M., Barkley, R.A., Smallish, L., Fletcher, K., 2005. Executive
functioning in hyperactive children as young adults: attention,
inhibition, response perseveration, and the impact of comorbidi-
ty. Dev. Neuropsychol. 27, 107—133.
Good, M.A., Barnes, P., Staal, V., McGregor, A., Honey, R.C., 2007.
Context- but not familiarity-dependent forms of object recogni-
tion are impaired following excitotoxic hippocampal lesions in
rats. Behav. Neurosci. 121, 218—223.
Harrison, A.A., Everitt, B.J., Robbins, T.W., 1997. Doubly dissociable
effects of median- and dorsal-raphe lesions on the performance of
the five-choice serial reaction time test of attention in rats.
Behav. Brain Res. 89, 135—149.
Hermes, G.L., Jacobs, L.F., McClintock, M.K., 2005. The sectored
foraging field: a novel design to quantify spatial strategies,
learning, memory, and emotion. Neurobiol. Learn. Mem. 84,
69—73.
Humby, T., Laird, F.M., Davies, W., Wilkinson, L.S., 1999. Visuospatial
attentional functioning in mice: interactions between cholinergic
manipulations and genotype. Eur. J. Neurosci. 11,
2813—2823.
Jamain, S., Quach, H., Betancur, C., Rastam, M., Colineaux, C.,
Gillberg, I.C., Soderstrom, H., Giros, B., Leboyer, M., Gillberg, C.,
Bourgeron, T., 2003. Mutations of the X-linked genes encoding
neuroligins NLGN3 and NLGN4 are associated with autism. Nat.
Genet. 34, 27—29.
Jonsson, L., Ljunggren, E., Bremer, A., Pedersen, C., Landen, M.,
Thuresson, K., Giacobini, M., Melke, J., 2010. Mutation screening
of melatonin-related genes in patients with autism spectrum
disorders. BMC Med. Genomics 3, 10.
Kasahara, T., Abe, K., Mekada, K., Yoshiki, A., Kato, T., 2010.
Genetic variation of melatonin productivity in laboratory
mice under domestication. Proc. Natl. Acad. Sci. U.S.A. 107,
6412—6417.
Kent, L., Emerton, J., Bhadravathi, V., Weisblatt, E., Pasco, G.,
Willatt, L.R., McMahon, R., Yates, J.R., 2008. X-linked ichthyosis
(steroid sulfatase deficiency) is associated with increased risk of
attention deficit hyperactivity disorder, autism and social com-
munication deficits. J. Med. Genet. 45, 519—524.
Korf, H.W., Von Gall, C., Stehle, J., 2003. The circadian system and
melatonin: lessons from rats and mice. Chronobiol. Int. 20, 697—
710.
Laumonnier, F., Bonnet-Brilhault, F., Gomot, M., Blanc, R., David, A.,
Moizard, M.P., Raynaud, M., Ronce, N., Lemonnier, E., Calvas, P.,
Laudier, B., Chelly, J., Fryns, J.P., Ropers, H.H., Hamel, B.C.,
Andres, C., Barthelemy, C., Moraine, C., Briault, S., 2004. X-
linked mental retardation and autism are associated with a
mutation in the NLGN4 gene, a member of the neuroligin family.
Am. J. Hum. Genet. 74, 552—557.
Le Pen, G., Grottick, A.J., Higgins, G.A., Moreau, J.L., 2003. Phen-
cyclidine exacerbates attentional deficits in a neurodevelopmen-
tal rat model of schizophrenia. Neuropsychopharmacology 28,
1799—1809.
Lonardo, F., Parenti, G., Luquetti, D.V., Annunziata, I., Della Monica,
M., Perone, L., De Gregori, M., Zuffardi, O., Brunetti-Pierri, N.,
Andria, G., Scarano, G., 2007. Contiguous gene syndrome due to
an interstitial deletion in Xp22.3 in a boy with ichthyosis, chon-
drodysplasia punctata, mental retardation and ADHD. Eur. J. Med.
Genet. 50, 301—308.Maruki, K., Izaki, Y., Hori, K., Nomura, M., Yamauchi, T., 2001.
Effects of rat ventral and dorsal hippocampus temporal
inactivation on delayed alternation task. Brain Res. 895,
273—276.
Mehler-Wex, C., Riederer, P., Gerlach, M., 2006. Dopaminergic dys-
balance in distinct basal ganglia neurocircuits: implications for
the pathophysiology of Parkinson’s disease, schizophrenia and
attention deficit hyperactivity disorder. Neurotox. Res. 10, 167—
179.
Melke, J., Goubran Botros, H., Chaste, P., Betancur, C., Nygren, G.,
Anckarsater, H., Rastam, M., Stahlberg, O., Gillberg, I.C.,
Delorme, R., Chabane, N., Mouren-Simeoni, M.C., Fauchereau,
F., Durand, C.M., Chevalier, F., Drouot, X., Collet, C., Launay,
J.M., Leboyer, M., Gillberg, C., Bourgeron, T., 2008. Abnormal
melatonin synthesis in autism spectrum disorders. Mol. Psychiatry
13, 90—98.
Mortaud, S., Nicolas, L., Pinoteau, W., Tordjman, S., Carlier, M.,
Roubertoux, P.L., 2010. Brain pathways mediating the pro-ag-
gressive effect of the steroid sulfatase (Sts) gene. Behav. Genet.
40, 211—219.
Muir, J.L., Everitt, B.J., Robbins, T.W., 1996. The cerebral cortex of
the rat and visual attentional function: dissociable effects of
mediofrontal, cingulate, anterior dorsolateral, and parietal cor-
tex lesions on a five-choice serial reaction time task. Cereb.
Cortex 6, 470—481.
Narita, N., Kato, M., Tazoe, M., Miyazaki, K., Narita, M., Okado, N.,
2002. Increased monoamine concentration in the brain and blood
of fetal thalidomide- and valproic acid-exposed rat: putative
animal models for autism. Pediatr. Res. 52, 576—579.
Nicolas, L.B., Pinoteau, W., Papot, S., Routier, S., Guillaumet, G.,
Mortaud, S., 2001. Aggressive behavior induced by the steroid
sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice. Brain
Res. 922, 216—222.
Oades, R.D., 2007. Role of the serotonin system in ADHD: treatment
implications. Expert Rev. Neurother. 7, 1357—1374.
Odorisio, T., Rodriguez, T.A., Evans, E.P., Clarke, A.R., Burgoyne,
P.S., 1998. The meiotic checkpoint monitoring synapsis eliminates
spermatocytes via p53-independent apoptosis. Nat. Genet. 18,
257—261.
O’Hare, A., 2009. Autism spectrum disorder: diagnosis and manage-
ment. Arch. Dis. Child. Educ. Pract. Ed. 94, 161—168.
Pearce, J.M., George, D.N., Haselgrove, M., Erichsen, J.T., Good,
M.A., 2005. The influence of hippocampal lesions on the discrimi-
nation of structure and on spatial memory in pigeons (Columba
livia). Behav. Neurosci. 119, 1316—1330.
Reed, M.J., Purohit, A., Woo, L.W., Newman, S.P., Potter, B.V., 2005.
Steroid sulfatase: molecular biology, regulation, and inhibition.
Endocr. Rev. 26, 171—202.
Rhoads, D.E., Grimes, N., Kaushal, S., Mallari, J., Orlando, K.,
2012. Decision time and perseveration of adolescent rats in
the T-maze are affected differentially by buspirone and indepen-
dent of 5-HT-1A expression. Pharmacol. Biochem. Behav. 102,
58—63.
Rhodes, M.E., Li, P.K., Burke, A.M., Johnson, D.A., 1997. Enhanced
plasma DHEAS, brain acetylcholine and memory mediated by
steroid sulfatase inhibition. Brain Res. 773, 28—32.
Robbins, T.W., 2002. The 5-choice serial reaction time task: beha-
vioural pharmacology and functional neurochemistry. Psycho-
pharmacology (Berl.) 163, 362—380.
Rommelse, N.N., Franke, B., Geurts, H.M., Hartman, C.A., Buitelaar,
J.K., 2010. Shared heritability of attention-deficit/hyperactivity
disorder and autism spectrum disorder. Eur. Child Adolesc. Psy-
chiatry 19, 281—295.
Scott, M.M., Deneris, E.S., 2005. Making and breaking serotonin
neurons and autism. Int. J. Dev. Neurosci. 23, 277—285.
Shinawi, M., Patel, A., Panichkul, P., Zascavage, R., Peters, S.U.,
Scaglia, F., 2009. The Xp contiguous deletion syndrome and
autism. Am. J. Med. Genet. A 149A, 1138—1148.
1380 S. Trent et al.Shull, R.N., Holloway, F.A., 1985. Behavioral effects of hippocampal
system lesions on rats in an operant paradigm. Brain Res. Bull. 14,
315—322.
Stergiakouli, E., Langley, K., Williams, H., Walters, J., Williams,
N.M., Suren, S., Giegling, I., Wilkinson, L.S., Owen, M.J., O’Dono-
van, M.C., Rujescu, D., Thapar, A., Davies, W., 2011. Steroid
sulfatase is a potential modifier of cognition in attention deficit
hyperactivity disorder. Genes Brain Behav. 10, 334—344.
Strous, R.D., Spivak, B., Yoran-Hegesh, R., Maayan, R., Averbuch, E.,
Kotler, M., Mester, R., Weizman, A., 2001. Analysis of neuroster-
oid levels in attention deficit hyperactivity disorder. Int. J.
Neuropsychopharmacol. 4, 259—264.
Thapar, A., Cooper, M., Jefferies, R., Stergiakouli, E., 2012. What
causes attention deficit hyperactivity disorder? Arch. Dis. Child.
97, 260—265.
Thomas, N.S., Sharp, A.J., Browne, C.E., Skuse, D., Hardie, C.,
Dennis, N.R., 1999. Xp deletions associated with autism in three
females. Hum. Genet. 104, 43—48.
Trent, S., Cassano, T., Bedse, G., Ojarikre, O.A., Humby, T., Davies,
W., 2012a. Altered serotonergic function may partially accountfor behavioral endophenotypes in steroid sulfatase-deficient
mice. Neuropsychopharmacology 37, 1267—1274.
Trent, S., Dennehy, A., Richardson, H., Ojarikre, O.A., Burgoyne,
P.S., Humby, T., Davies, W., 2012b. Steroid sulfatase-
deficient mice exhibit endophenotypes relevant to attention
deficit hyperactivity disorder. Psychoneuroendocrinology 37,
221—229.
Tsuchiya, E., Oki, J., Yahara, N., Fujieda, K., 2005. Computerized
version of the Wisconsin card sorting test in children with high-
functioning autistic disorder or attention-deficit/hyperactivity
disorder. Brain Dev. 27, 233—236.
Vorstman, J.A., Staal, W.G., van Daalen, E., van Engeland, H.,
Hochstenbach, P.F., Franke, L., 2006. Identification of novel
autism candidate regions through analysis of reported cytogenet-
ic abnormalities associated with autism. Mol. Psychiatry 11 (1),
18—28.
Wang, L.J., Huang, Y.S., Hsiao, C.C., Chiang, Y.L., Wu, C.C., Shang,
Z.Y., Chen, C.K., 2011. Salivary dehydroepiandrosterone, but not
cortisol, is associated with attention deficit hyperactivity disor-
der. World J. Biol. Psychiatry 12, 99—109.
